Solventum Co. (NYSE:SOLV) Shares Bought by Poehling Capital Management INC.

Poehling Capital Management INC. boosted its holdings in shares of Solventum Co. (NYSE:SOLV - Free Report) by 271.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 30,551 shares of the company's stock after buying an additional 22,321 shares during the quarter. Poehling Capital Management INC.'s holdings in Solventum were worth $2,018,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Clarity Asset Management Inc. purchased a new position in Solventum during the 4th quarter worth approximately $25,000. Stonebridge Financial Group LLC acquired a new stake in shares of Solventum during the 4th quarter worth approximately $26,000. Raiffeisen Bank International AG acquired a new stake in shares of Solventum during the 4th quarter worth approximately $29,000. Crews Bank & Trust acquired a new stake in shares of Solventum during the 4th quarter worth approximately $32,000. Finally, Colonial Trust Co SC grew its stake in shares of Solventum by 240.7% during the 4th quarter. Colonial Trust Co SC now owns 511 shares of the company's stock worth $34,000 after purchasing an additional 361 shares during the period.

Analysts Set New Price Targets

A number of brokerages have recently commented on SOLV. The Goldman Sachs Group raised their price objective on shares of Solventum from $63.00 to $71.00 and gave the stock a "sell" rating in a research note on Monday, March 3rd. Wells Fargo & Company raised their price objective on shares of Solventum from $73.00 to $75.00 and gave the stock an "equal weight" rating in a research note on Friday, February 28th. Piper Sandler raised shares of Solventum from a "neutral" rating to an "overweight" rating and raised their price objective for the stock from $78.00 to $87.00 in a research note on Monday, May 19th. Morgan Stanley raised their price objective on shares of Solventum from $73.00 to $80.00 and gave the stock an "equal weight" rating in a research note on Wednesday, March 5th. Finally, Bank of America raised their price objective on shares of Solventum from $80.00 to $85.00 and gave the stock a "neutral" rating in a research note on Wednesday, February 26th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $80.29.

Solventum Price Performance

Solventum stock traded down $1.81 during trading on Friday, reaching $70.85. The company had a trading volume of 1,119,844 shares, compared to its average volume of 1,246,786. The firm's 50-day simple moving average is $69.71 and its 200 day simple moving average is $71.29. Solventum Co. has a 1-year low of $47.16 and a 1-year high of $85.92. The firm has a market capitalization of $12.26 billion and a PE ratio of 32.80. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15.

Solventum (NYSE:SOLV - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported $1.34 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.19 by $0.15. The company had revenue of $2.07 billion during the quarter, compared to analyst estimates of $2.02 billion. During the same period in the prior year, the business posted $2.08 EPS. Solventum's revenue was up 2.7% compared to the same quarter last year. As a group, equities research analysts anticipate that Solventum Co. will post 6.58 earnings per share for the current fiscal year.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.